FDA Issues Multiple Sclerosis Drug Alert
FDA Issues Multiple Sclerosis Drug Alert
MONDAY, May 14 (HealthDay News) -- The multiple sclerosis drug Gilenya (fingolimod) should not be given to patients with certain pre-existing or recent heart conditions or stroke, or those taking certain medications to correct heart rhythm problems, says a U.S. Food and Drug Administration safety announcement issued Monday. read more..
source:http://yhoo.it/LN82V1
FDA Issues Multiple Sclerosis Drug Alert
MONDAY, May 14 (HealthDay News) -- The multiple sclerosis drug Gilenya (fingolimod) should not be given to patients with certain pre-existing or recent heart conditions or stroke, or those taking certain medications to correct heart rhythm problems, says a U.S. Food and Drug Administration safety announcement issued Monday. read more..
source:http://yhoo.it/LN82V1
No comments:
Post a Comment